Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] This mega SME issue is aggressively priced despite super performance for FY21. Gujarat is becoming the most preferred destination for health-related treatments and the management is emphasizing a low-cost operation model with ultramodern equipment and facility. Considering the base of equity, chances for migration to the mainboard in the near future, post listing, is most likely. Hence, cash surplus/risk seekers may consider parking of their funds. Read detail review...
Aashka Hospitals IPO Reviews, analysis and views by popular members. Read Aashka Hospitals Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note: